You can find the annual or quarterly income statement of Polaryx Therapeutics Ord Shs here for insights into the performance and operational efficiency of Polaryx Therapeutics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q3

Operating expenses

--1.96M

--974.00K

R&D expenses

--679.00K

--514.00K

Operating profit

---1.96M

---974.00K

Net non-operating interest income (expenses)

Special income (expenses)

----

--0.00

Other non-operating income (expenses)

----

---456.00K

Income before tax

----

---1.43M

Income after tax

----

---1.43M

Net income from continuous operations

----

---1.43M

Net income attributable to controlling interests

----

---1.43M

Net income attributable to common shareholders

----

---1.43M

Basic earnings per share

---0.05

---0.03

Diluted earnings per share

---0.05

---0.03

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

